Pd Rx Valuation
| PDRX Stock | USD 3.33 0.00 0.00% |
At this time, the company appears to be fairly valued. Pd Rx Pharmaceutical owns a latest Real Value of $3.45 per share. The recent price of the company is $3.33. Our model determines the value of Pd Rx Pharmaceutical from evaluating the company fundamentals such as return on asset of 0.0556, and Revenue of 21.6 M as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Pd Rx's price fluctuation is slightly risky at this time. Calculation of the real value of Pd Rx Pharmaceutical is based on 3 months time horizon. Increasing Pd Rx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Pd Rx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PDRX Pink Sheet. However, Pd Rx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.33 | Real 3.45 | Hype 3.33 | Naive 3.43 |
The intrinsic value of Pd Rx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pd Rx's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pd Rx Pharmaceutical helps investors to forecast how PDRX pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pd Rx more accurately as focusing exclusively on Pd Rx's fundamentals will not take into account other important factors: About Pd Rx Valuation
Our relative valuation model uses a comparative analysis of Pd Rx. We calculate exposure to Pd Rx's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pd Rx's related companies.PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. Pd-Rx Pharmaceutical operates under Medical Distribution classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Pd Rx's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pd Rx's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pd Rx's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pd Rx's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pd Rx's revenue streams: Identify Pd Rx's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pd Rx's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pd Rx's growth potential: Evaluate Pd Rx's management, business model, and growth potential.
- Determine Pd Rx's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pd Rx's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pd Rx Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Quarterly Earnings Growth Y O Y | 0.604 | |
| Retained Earnings | 7.4 M |
Additional Tools for PDRX Pink Sheet Analysis
When running Pd Rx's price analysis, check to measure Pd Rx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd Rx is operating at the current time. Most of Pd Rx's value examination focuses on studying past and present price action to predict the probability of Pd Rx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd Rx's price. Additionally, you may evaluate how the addition of Pd Rx to your portfolios can decrease your overall portfolio volatility.